You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Joseph L. Goldstein

Chairman, Department of Molecular Genetics at The University of Texas - Southwestern Medical Center
Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the over 1.5 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are Joseph L. Goldstein's strongest connections.

People Most Closely Connected to Joseph L. Goldstein

Click the names below to expand relationship details.
Michael S. Brown
Director of the Jonsson Center for Molecular Genetics at University of Texas - Southwestern Medical School
Marc Tessier-Lavigne
President at Stanford University
Phillip A. Sharp
Co-Founder at Alnylam Pharmaceuticals, Inc.
David Baltimore
Non-Resident Fellow at The Salk Institute for Biological Studies
Tom Maniatis
Co-Founder at Genetics Institute
Craig B. Thompson
President & Chief Executive Officer at Memorial Sloan Kettering Cancer Center
Richard Axel
Founder at Kallyope, Inc.
Paul Nurse
Head, Laboratory of Yeast Genetics & Cell Biology at The Rockefeller University
Shirley M. Tilghman
President Emeritus at Princeton University
Elaine Fuchs
Investigator at Howard Hughes Medical Institute, Inc.
Richard Klausner
Co-Founder at Juno Therapeutics, Inc.
Huda Zoghbi
Director, Jan & Dan Duncan Neurological Research Institute at Texas Children's Hospital
Charles L. Sawyers
Chairman, Human Oncology & Pathogenesis Program at Memorial Sloan Kettering Cancer Center
Richard O. Hynes
Investigator at Howard Hughes Medical Institute, Inc.
Robert J. Lefkowitz
Investigator at Howard Hughes Medical Institute, Inc.
David V. Goeddel
Managing Partner (All) at The Column Group Management LP
Steven L. McKnight
Professor & Chairman-Biochemistry Department at The University of Texas - Southwestern Medical Center
Richard Scheller
Chief Science Officer & Head of Therapeutics at 23andMe, Inc.
3,049 more connections are available with a RelSci Professional subscription.